Liqbiopsens present on the FIRST INTERNATIONAL SYMPOSIUM on LIQUID BIOPSIES 2016

RSS de esta página

29/09/2016

Imagen Noticia

Hugh Ilyine, CEO of DestiNA Genomics present the Liqbiopsens project on the FIRST INTERNATIONAL SYMPOSIUM on LIQUID BIOPSIES 2016, on a satelyte symposium called Liqbiopsens- "an EU Horizon 2020 consortium, combining novel technologies to deliver a faster, more reliable liquid biopsy colon cancer assay." he shows the aim and possibilies of the new era of liquid biopsy and the role of a group like Liqbiopsens as a reference on this field.

 

Picture source: @LiqBiopConfe16 twitter account.

+ info:

Advance Wave Sensors SL
Destina Genomics Ltd.
Foundation for Research & Technology - Hellas
Servicio Andaluz de Salud - Hospital Universitario San Cecilio Granada
Sistemas Genómicos SL
Université Catholique de Louvain - ICTEAM
Co-funded by the Horizon 2020 Framework Programme of the European Union